Post-Menopausal Vaginal Hemorrhage Related to the Use of a Hop-Containing Phytotherapeutic Product
Drug Safety - Case Reports · 2015
DOI: 10.1007/s40800-015-0016-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Safety - Case Reports, 2015. Verfasst von Florence van Hunsel und 2 weiteren Autor:innen. Beteiligte Einrichtung: Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, 's Hertogenbosch, The Netherlands. f.vanhunsel@lareb.nl. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Two 54-year-old women developed abdominal cramps and vaginal hemorrhage as a result of endometrial hyperplasia during treatment with a hop-containing phytotherapeutic product (MenoCool®) for post-menopausal complaints. The women used the hop-containing phytotherapeutic product (418 mg of hop per tablet) twice daily (1 and 0.5 tablets by both patient A and B). Patient A developed abdominal cramps and vaginal hemorrhage after 2 months of use. After gynecological examination, she was diagnosed with endometrial hyperplasia. The patient was treated with a curettage. The hop-containing phytotherapeutic product was discontinued, and the patient recovered. Patient B developed abdominal pain/cramps and vaginal hemorrhage after 5 months of use. A cervix smear, internal examination, and ultrasound were performed. Due to the thickness of the endometrium, a pipelle endometrial biopsy was performed. Results showed no indication for cervix cancer. The use of MenoCool® was ceased; follow-up information received from the patient shortly thereafter indicated that she had almost entirely recovered from the abdominal pain/cramps and vaginal hemorrhage. Hop (Humulus lupulus) has phytoestrogenic properties that may be the cause of endometrial hyperplasia and subsequent vaginal hemorrhage. A Naranjo assessment score of 5 was obtained for both cases, indicating a probable relationship between the patient's endometrial proliferation and subsequent vaginal hemorrhage and their use of the suspect drug.
Autor:innen und Institutionen
- Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, 's Hertogenbosch, The Netherlands. f.vanhunsel@lareb.nl.
- Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, 's Hertogenbosch, The Netherlands.
- Department of Pharmacy, Pharmacotherapy and Pharmaceutical Care, University of Groningen, Groningen, The Netherlands.
Zitieren
APA
van Hunsel, F., van de Koppel, S., & van Puijenbroek, E. (2015). Post-Menopausal Vaginal Hemorrhage Related to the Use of a Hop-Containing Phytotherapeutic Product. Drug Safety - Case Reports. https://doi.org/10.1007/s40800-015-0016-2
Vancouver
van Hunsel F, van de Koppel S, van Puijenbroek E. Post-Menopausal Vaginal Hemorrhage Related to the Use of a Hop-Containing Phytotherapeutic Product. Drug Safety - Case Reports. 2015. doi:10.1007/s40800-015-0016-2
BibTeX
@article{vanHunsel2015,
author = {van Hunsel, Florence and van de Koppel, Sonja and van Puijenbroek, Eugène},
title = {Post-Menopausal Vaginal Hemorrhage Related to the Use of a Hop-Containing Phytotherapeutic Product},
journal = {Drug Safety - Case Reports},
year = {2015},
doi = {10.1007/s40800-015-0016-2}
}
EUVIMED